نتایج جستجو برای: ymdd mutant

تعداد نتایج: 129717  

2015
Wei Tang Lun Chen Ruohui Zheng Lingxiao Pan Jin Gao Xigang Ye Xiaoshen Zhang Wenbo Zheng Yury E Khudyakov

BACKGROUND Three strategies using lamivudine have been proposed to prevent chemotherapy-induced HBV (hepatitis B virus) reactivation in the clinical setting. The purpose of this meta-analysis is to evaluate the efficacy of the early preemptive strategy, deferred preemptive strategy and therapeutic strategy in patients with HBsAg-positive breast cancer during chemotherapy. METHODS Clinical stu...

2013
Songfeng Yu Hua Guo Li Zhuang Jun Yu Sheng Yan Min Zhang Weilin Wang Shusen Zheng

Post-transplant malignancy is the major cause of later death of recipients after liver transplantation. Tumor recurrence after liver transplantation for patients with hepatocellular carcinoma in the end stage of cirrhosis has been frequently encountered. However, de novo hepatocellular carcinoma originating from the liver allograft has only rarely been reported. Here we reported a case of de no...

Journal: :Hepatology International 2008
Shogo Ohkoshi Akira Yoshimura Satoshi Yamamoto Masahiko Yano So Kurita Kazuhide Yamazaki Yo-hei Aoki Satoshi Yamagiwa Hiroto Wakabayashi Motoya Sugiyama Tohru Takahashi Tohru Ishikawa Yasunobu Matsuda Takafumi Ichida Tomoteru Kamimura Yutaka Aoyagi

PURPOSE To study the changes in serum ferritin levels in lamivudine (LAM)-treated patients with chronic hepatitis and liver cirrhosis type B and determine whether successful treatment with LAM results in a reduction of serum ferritin levels. METHODS Thirty patients with chronic hepatitis B virus (HBV) infection were followed prospectively during their treatment with LAM for 12 months. Serum H...

Journal: :JPMA. The Journal of the Pakistan Medical Association 2009
Huma Qureshi Ambreen Arif Waquaruddin Ahmed Syed Ejaz Alam

Lamivudine exhibits potent antiviral activity in chronic hepatitis B. YMDD mutations in west is around 32% (5 years) but reports from East are scarce. To evaluate frequency of lamivudine resistance and compare the results with the West, a total of 100 chronic hepatitis B patients were given Lamivudine 100 mg before breakfast. Out of 81 patients (19 no follow up), (85%) males and (15%) females. ...

Journal: :Journal of the Chinese Medical Association : JCMA 2008
Jeng-Hsiu Hung Chi-Jen Chu Pi-Lin Sung Chih-Yao Chen Kuan-Chong Chao Ming-Jie Yang Selena Chia-Yi Hung

We report a case of chronic hepatitis B carrier gravida who had acute exacerbation during pregnancy. She had been taking lamivudine 100 mg/qd for 17 months when hepatitis B virus (HBV) DNA in the YMDD region of the polymerase gene (YMDD motif) mutant was noted. After discontinuing lamivudine, she became pregnant. HBeAg became positive again and liver enzymes were elevated during the first trime...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006
Vivian Levy Robert M Grant

Coinfections with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are common globally. HIV infection modifies the course of HBV infection by increasing rates of chronicity, prolonging HBV viremia, and increasing liver-related morbidity. To minimize the emergence of HIV and/or HBV resistance, as well as the emergence of liver enzyme flares, the treatment of both infections should ...

Journal: :Asian Journal of Transfusion Science 2011

بهمنش, مهرداد, حسینخانی, سامان, صادقی زاده, مجید, بهرامعلی, گلناز , خجاره, لیلا ,

سابقه و هدف: هپاتیت B، بیماری بسیار خطرناکی است که به صورت اندمیک در بسیاری از مناطق جهان مشاهده می شود.ویروس هپاتیت   (HBV) نسبت به یک سری داروهای ضد ویروسی از جمله لامیوودین حساس بوده (%98)، بطوری که به نواحی خاصی از آنزیم DNA پلی مراز ویروس متصل می گردد و مانع عمل ترانس کریپتاز معکوس و همانند سازی DNA ویروسی می شود. در اثر مصرف طولانی مدت دارو، جهشی در موتیف YMDD در دومین C ژن پلیمراز ویروس ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید